Trial · NCT04612374
Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia
NCT04612374, Not applicable, Completed, Duke University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia. Trials, record NCT04612374. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04612374
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia
- NCT number
- NCT04612374
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 18 participants, actual
- Lead sponsor
- Duke University
- Conditions
- Misophonia
- Interventions
- Unified Protocol for Transdiagnostic Treatment of Emotional Disorders, Revised Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
- First posted
- 2020-11-03
- Last updated
- 2022-08-16
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ | up to 20 weeks | The CEQ is a 6-item measure that asks patients about their perceptions of treatment. |
| Primary | Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable) | up to 20 weeks | The Satisfaction with Therapy and Therapist Scale is a 13-item measure that asks patients about their satisfaction with treatment and with their therapist. |
| Primary | Number of sessions attended | up to 20 weeks | The number of sessions attended will provide an estimate of the feasibility of attending and completing this treatment |
| Primary | Number of patients who use mindfulness skills assessed by the Southampton Mindfulness Questionnaire (SMQ) | up to 24 weeks | The SMQ is a 16-item measure that asks patients about their use of mindfulness skills . |
| Primary | Number of patients who use cognitive flexibility skills assessed by the UP Cognitive Skills Questionnaire (CSQ) | up to 24 weeks | The CSQ is a 10-item measure that assesses use of cognitive skills taught in treatment |
| Primary | Number of Patients who use behavior change skills assessed by the UP Behavioral Avoidance Questionnaire (BAQ) | up to 24 weeks | The BAQ is a five item measure that assesses use of behavior change skills taught in treatment. |
| Primary | Number of patients who report a decrease in anxiety sensitivity on the Anxiety Sensitivity Index (ASI) | up to 24 weeks | The ASI is an 18 measure that assesses how often a participant experiences anxiety symptoms |
| Primary | Number of Patients who use behavior change skills assessed by the Brief Experiential Avoidance Questionnaire (BEAQ) | up to 24 weeks | The BEAQ is a 13 item measure that assesses how often a participant avoids emotion-provoking situations |
| Primary | Change in misophonia symptoms as assessed by the Misophonia Questionnaire | assessed weekly, up to 24 weeks | The Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity. The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true). These two parts are summed to produce a total score ranging from 0 - 68. The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities). |
| Primary | Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scale | assessed weekly, up to 24 weeks | The Overall Anxiety Severity and Impairment Scale is a five item measure that assesses interference and distress related to the experience of anxiety. Items are scored from 0 to 4 and summed to produce a total score (ranging from 0 - 20), with higher scores indicating greater functional impairment. |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04612374
GET https://conductscience.org/api/trials/v1/NCT04612374/registered